Stroke Trial, Recruiting (NCT05134454)

Stroke Trial, Recruiting NCT05134454 Sponsor: Karolinska Institutet Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT05134454 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 70 years old or older.
People who have been diagnosed with an ischemic stroke (a stroke caused by a blood clot) or a TIA (sometimes called a "mini-stroke") within the last 14 days.

Who may not be able to join:

People who have already been diagnosed with atrial fibrillation (an irregular heartbeat condition).
People for whom blood-thinning medication (oral anticoagulants) is not medically suitable, based on standard prescribing guidelines.
People who need blood-thinning medication for a reason other than atrial fibrillation, such as a blood clot in the veins or an artificial heart valve.
People who are on two types of antiplatelet (blood-clot-preventing) medications that cannot be safely switched to a blood-thinning tablet.
People who have a pacemaker, an implantable heart rhythm device (cardioverter defibrillator), or an implantable heart monitoring device.
People whom the trial doctor believes will not be able to follow the study requirements and schedule.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Johan Engdahl, MD, PhD, Karolinska Institutet

Phone: +46737593374

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05134454

Sponsor: Karolinska Institutet

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: +46737593374

More information: https://clinicaltrials.gov/study/NCT05134454

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 70 years old or older.
People who have been diagnosed with an ischemic stroke (a stroke caused by a blood clot) or a TIA (sometimes called a "mini-stroke") within the last 14 days.

Who may not be able to join:

People who have already been diagnosed with atrial fibrillation (an irregular heartbeat condition).
People for whom blood-thinning medication (oral anticoagulants) is not medically suitable, based on standard prescribing guidelines.
People who need blood-thinning medication for a reason other than atrial fibrillation, such as a blood clot in the veins or an artificial heart valve.
People who are on two types of antiplatelet (blood-clot-preventing) medications that cannot be safely switched to a blood-thinning tablet.
People who have a pacemaker, an implantable heart rhythm device (cardioverter defibrillator), or an implantable heart monitoring device.
People whom the trial doctor believes will not be able to follow the study requirements and schedule.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Karolinska Institutet

Registry

ClinicalTrials.gov

Start date

20 January 2022

Est. completion

1 December 2025

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Composite of stroke, death and intracerebral bleeding

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov